Q-omics provides the consensus-scored RNY3P5 profile across patient tissues and cancer cell-line models. RNY3P5 expression is associated with patient survival in 8 of 34 cancer types, with the highest sampling consensus in LUSC. Additionally, RNY3P5 RNA expression shows 9,329 significant gene co-expression associations, with the highest sampling consensus in ESCA. Together, these results highlight LUSC, and ESCA as cancer lineages where RNY3P5 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.